Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 28, 2008; 14(12): 1891-1897
Published online Mar 28, 2008. doi: 10.3748/wjg.14.1891
Published online Mar 28, 2008. doi: 10.3748/wjg.14.1891
Table 5 Risk assessment according to the KIT/PDGFRA mutations
| Risk assessment | ||||||
| Benign (%) | Very low malignant potential (%) | Low malignant potential (%) | Low moderate malignant potential (%) | Malignant (%) | P | |
| KIT mutation | ||||||
| Positive | 10.5 | 10.5 | 21.1 | 57.9 | 0.003 | |
| Negative | 63.6 | 9.1 | 18.2 | 9.1 | ||
| Exon 9 | 33.3 | 66.7 | 0.036 | |||
| Exon 11 | 12.5 | 6.3 | 25 | 56.3 | ||
| PDGFRA mutation | ||||||
| Positive | NS | |||||
| Negative | 50 | 50 | ||||
- Citation: Kontogianni-Katsarou K, Dimitriadis E, Lariou C, Kairi-Vassilatou E, Pandis N, Kondi-Paphiti A. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol 2008; 14(12): 1891-1897
- URL: https://www.wjgnet.com/1007-9327/full/v14/i12/1891.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1891